Your session is about to expire
← Back to Search
Corticosteroid
Decision Support Tool for Premature Birth
N/A
Recruiting
Led By Jessica Liauw, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 months following implementation of the intervention.
Awards & highlights
Study Summary
This trial will test whether a decision support tool can help doctors communicate the benefits of antenatal corticosteroid treatment to patients who may deliver between 34 and 36 weeks of pregnancy.
Who is the study for?
This trial is for English-speaking individuals aged 18 or older who have given birth to a live baby between 34+0 and 36+6 weeks of gestation at one of the six participating hospitals. They must agree to complete a questionnaire in their first week post-partum.Check my eligibility
What is being tested?
The study is testing whether using a decision support tool helps doctors better discuss antenatal corticosteroid treatment with patients likely to deliver prematurely, specifically between 34 and 36 weeks of pregnancy.See study design
What are the potential side effects?
Since this trial involves a decision support tool rather than medication, there are no direct medical side effects. However, it may impact patient satisfaction or decision-making processes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 8 months following implementation of the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 months following implementation of the intervention.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
Secondary outcome measures
The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Guideline + decision support toolExperimental Treatment1 Intervention
A decision support tool summarizing harms and benefits of late preterm antenatal corticosteroids will be integrated into the clinical practice guideline available to clinicians in the hospitals in the experimental arm.
Group II: Guideline onlyActive Control1 Intervention
Clinicians in the hospitals in the 'no-intervention' arm will have access to the standard guideline only (without the integrated decision support tool).
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,556 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,253 Total Patients Enrolled
Jessica Liauw, MDPrincipal InvestigatorUniversity of British Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- There are no specific requirements to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Guideline + decision support tool
- Group 2: Guideline only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this trial currently available?
"Affirmative. According to clinicaltrials.gov, this medical study launched on May 20th 2022 and has been actively recruiting since then. Currently, the trial is enrolling 460 patients across two distinct sites."
Answered by AI
How many people have been invited to participate in this experiment?
"Affirmative. According to clinicaltrials.gov, this scientific trial is actively recruiting patients since its inception on May 20th 2022; the listing was last updated on May 30th of that same year. 460 people need to be enrolled between 2 medical sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger